Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.39 | Why? |
T-Lymphocytes | 2 | 2021 | 6670 | 0.32 | Why? |
Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.27 | Why? |
Epitope Mapping | 1 | 2021 | 1240 | 0.15 | Why? |
Mice, Inbred BALB C | 3 | 2021 | 5814 | 0.15 | Why? |
Interferon-beta | 1 | 2020 | 979 | 0.14 | Why? |
Vero Cells | 5 | 2021 | 14117 | 0.13 | Why? |
Signal Transduction | 2 | 2021 | 7207 | 0.13 | Why? |
Coronavirus NL63, Human | 1 | 2020 | 669 | 0.13 | Why? |
NF-kappa B | 1 | 2021 | 1301 | 0.13 | Why? |
Mice, Transgenic | 1 | 2020 | 2739 | 0.13 | Why? |
Mice, Inbred C57BL | 2 | 2021 | 5542 | 0.13 | Why? |
Cross Reactions | 2 | 2021 | 4374 | 0.12 | Why? |
Interferon-alpha | 1 | 2020 | 1442 | 0.12 | Why? |
Disease Models, Animal | 2 | 2020 | 10998 | 0.12 | Why? |
Camelus | 1 | 2020 | 1425 | 0.11 | Why? |
Cysteine Endopeptidases | 1 | 2020 | 1557 | 0.11 | Why? |
Proteomics | 1 | 2021 | 2481 | 0.10 | Why? |
CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.09 | Why? |
Middle East Respiratory Syndrome Coronavirus | 2 | 2021 | 8843 | 0.09 | Why? |
Nanoparticles | 1 | 2021 | 2040 | 0.09 | Why? |
STAT1 Transcription Factor | 2 | 2020 | 313 | 0.09 | Why? |
Vascular Resistance | 1 | 2009 | 148 | 0.09 | Why? |
Blood Flow Velocity | 1 | 2009 | 193 | 0.09 | Why? |
Interferon Type I | 1 | 2021 | 2789 | 0.09 | Why? |
CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.08 | Why? |
Drug Discovery | 1 | 2021 | 3092 | 0.08 | Why? |
Zoonoses | 1 | 2020 | 3034 | 0.08 | Why? |
Animals | 7 | 2021 | 78931 | 0.07 | Why? |
Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.06 | Why? |
Acrylates | 1 | 2021 | 34 | 0.06 | Why? |
Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
Specific Pathogen-Free Organisms | 1 | 2020 | 358 | 0.05 | Why? |
Transduction, Genetic | 1 | 2020 | 273 | 0.05 | Why? |
Ubiquitins | 1 | 2020 | 202 | 0.05 | Why? |
Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
DEAD Box Protein 58 | 1 | 2020 | 250 | 0.04 | Why? |
Interferon Regulatory Factor-3 | 1 | 2020 | 379 | 0.04 | Why? |
Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.04 | Why? |
Blood Pressure | 1 | 2009 | 2198 | 0.04 | Why? |
SARS Virus | 1 | 2021 | 13021 | 0.04 | Why? |
HeLa Cells | 1 | 2021 | 1303 | 0.04 | Why? |
HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
Hepatocytes | 1 | 2020 | 549 | 0.04 | Why? |
Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
Adaptor Proteins, Signal Transducing | 1 | 2020 | 502 | 0.04 | Why? |
Mice | 3 | 2021 | 21357 | 0.04 | Why? |
Receptors, Immunologic | 1 | 2020 | 555 | 0.04 | Why? |
Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
Mice, Knockout | 1 | 2020 | 1815 | 0.04 | Why? |
A549 Cells | 1 | 2021 | 2066 | 0.04 | Why? |
Coronavirus Infections | 5 | 2020 | 253789 | 0.04 | Why? |
Vaccination | 1 | 2020 | 19050 | 0.03 | Why? |
Adenoviridae | 1 | 2020 | 1151 | 0.03 | Why? |
Protein Interaction Domains and Motifs | 1 | 2021 | 2134 | 0.03 | Why? |
RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
Nigeria | 1 | 2020 | 2292 | 0.03 | Why? |
RNA-Binding Proteins | 1 | 2020 | 1022 | 0.03 | Why? |
Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
Renal Dialysis | 1 | 2009 | 4358 | 0.03 | Why? |
Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.03 | Why? |
Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
Recombinant Proteins | 1 | 2020 | 3786 | 0.03 | Why? |
Interferon-gamma | 1 | 2020 | 2711 | 0.03 | Why? |
Macrophages | 1 | 2021 | 2784 | 0.02 | Why? |
Monocytes | 1 | 2021 | 2978 | 0.02 | Why? |
Drug Evaluation, Preclinical | 1 | 2020 | 3347 | 0.02 | Why? |
Inflammation | 2 | 2021 | 13255 | 0.02 | Why? |
Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
Genotype | 1 | 2020 | 4697 | 0.02 | Why? |
Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
Gene Expression Regulation | 1 | 2020 | 4020 | 0.02 | Why? |
Electric Impedance | 1 | 2009 | 283 | 0.02 | Why? |
Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
Humans | 11 | 2021 | 930598 | 0.02 | Why? |
Male | 6 | 2021 | 367725 | 0.02 | Why? |
Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
Female | 6 | 2021 | 380317 | 0.02 | Why? |
Aged | 4 | 2020 | 215776 | 0.01 | Why? |
Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
Infant | 1 | 2020 | 30274 | 0.01 | Why? |
Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
Adult | 3 | 2020 | 244371 | 0.01 | Why? |
Middle Aged | 3 | 2020 | 270681 | 0.01 | Why? |
China | 1 | 2020 | 50654 | 0.01 | Why? |
Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
Lung | 1 | 2020 | 31049 | 0.01 | Why? |
Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Cross-Sectional Studies | 1 | 2009 | 53120 | 0.00 | Why? |
Zhuang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(202)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_